Excelsior Medical Co (TPE:4104) Tax Expense: NT$217 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4104 Excelsior Medical Co Ltd TPE:4104
87 GF Score
Price NT$70.00
GF Value NT$87.70
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Excelsior Medical Co Tax Expense?

Excelsior Medical Co TPE:4104 -1.13% 87 Tax Expense is NT$217 Mil as of Mar. 2026. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.70 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Excelsior Medical Co's tax expense for the months ended in Mar. 2026 was NT$57 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was NT$217 Mil.


Excelsior Medical Co  (TPE:4104) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Excelsior Medical Co Tax Expense Related Terms


Excelsior Medical Co Tax Expense Historical Data

* Premium members only.

The historical data trend for Excelsior Medical Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Medical Co Tax Expense Chart

Excelsior Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.45 178.40 221.23 203.31 216.30

Excelsior Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.03 59.00 51.16 49.11 57.43
TPE:4104
87GF Score
Excelsior Medical Co Ltd TPE:4104
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excelsior Medical Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$217 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of NT$217 Mil mean?
Excelsior Medical Co (TPE:4104) has a Tax Expense of NT$217 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Excelsior Medical Co and its competitors.
Is Excelsior Medical Co's Tax Expense too high?
Excelsior Medical Co's current Tax Expense is NT$217 Mil. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's Tax Expense compare to MCK and COR?
Excelsior Medical Co's Tax Expense of NT$217 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Distribution company?
A good Tax Expense depends on the Medical Distribution industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Excelsior Medical Co and its competitors. Excelsior Medical Co's current Tax Expense is NT$217 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.70, compared to a current price of NT$70.00 — trading 20.2% below its estimated fair value. The current Tax Expense is NT$217 Mil. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current Tax Expense is NT$217 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued. The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.70. GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.

Key valuation signals for TPE:4104:

  • Tax Expense: NT$217 Mil
  • GF Value™: NT$87.70 vs. price of NT$70.00 (20.2% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Medical Co Business Description

Address Zhongzheng Road, No. 880, 17th Floor, Zhonghe District, New Taipei City, TWN, 235
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score

Get the complete analysis for TPE:4104

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.00
Price
NT$87.70
GF Value